Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Lisata Therapeutics (LSTA) over the last 3 years, with Q3 2025 value amounting to $183000.0.

  • Lisata Therapeutics' Interest & Investment Income fell 5942.35% to $183000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 5394.74%. This contributed to the annual value of $1.9 million for FY2024, which is 3087.37% down from last year.
  • As of Q3 2025, Lisata Therapeutics' Interest & Investment Income stood at $183000.0, which was down 5942.35% from $216000.0 recorded in Q2 2025.
  • Lisata Therapeutics' 5-year Interest & Investment Income high stood at $714000.0 for Q3 2023, and its period low was $183000.0 during Q3 2025.
  • For the 3-year period, Lisata Therapeutics' Interest & Investment Income averaged around $479181.8, with its median value being $493000.0 (2024).
  • In the last 5 years, Lisata Therapeutics' Interest & Investment Income crashed by 1208.96% in 2024 and then plummeted by 5942.35% in 2025.
  • Lisata Therapeutics' Interest & Investment Income (Quarter) stood at $671000.0 in 2023, then plummeted by 47.84% to $350000.0 in 2024, then tumbled by 47.71% to $183000.0 in 2025.
  • Its Interest & Investment Income stands at $183000.0 for Q3 2025, versus $216000.0 for Q2 2025 and $266000.0 for Q1 2025.